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Abstract: Inflammatory diseases affect a large portion of the worldwide population, and chronic
inflammation is a major risk factor for several dangerous pathologies. To limit the side effects of both
synthetic and biological anti-inflammatory drugs, the use of herbal medicines, nutraceuticals and
food supplements has increased tremendously as alternative and/or complementary medicine to
treat several pathologies, including inflammation. During the last decades, the biological properties
of Citrus bergamia (bergamot) derivatives have obtained important scientific achievements, and it has
been suggested their use in a context of a multitarget pharmacological strategy. Here, we present
an overview of the anti-inflammatory properties of bergamot extracts that could represent the
scientific basis for develop novel and alternative strategies to improve health status and attenuate
inflammatory conditions.
Keywords: bergamot; Citrus bergamia; inflammation; antioxidant activity; flavonoids; natural
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1. Introduction
Inflammation is a complex biological reaction induced by the disruption of the tissue homeostasis,
occurring in response to the presence of a biological, chemical, or physical agent in the body [1].
The classical key features of inflammation are redness, warmth, swelling, and pain. Inflammation can
be acute or chronic, depending on the type of stimulus and the effectiveness of the inflammatory process
resolution. Acute inflammation begins quickly and lasts a few hours or a few days. It is characterized
by the exudation of fluid and plasma proteins as well as leukocyte emigration (mainly neutrophils).
When the immune system successfully eliminates damaging agents in acute inflammation, the reaction
disappears, but if the response fails to remove them, a chronic phase occurs. Inflammation cascades can
lead to the development of diseases such as chronic asthma, rheumatoid arthritis, multiple sclerosis,
inflammatory bowel disease, and psoriasis. Chronic inflammation is associated with the presence of
lymphocytes and macrophages, vascular proliferation, fibrosis, and tissue destruction. Experimental
and clinical studies together with epidemiological observations have identified the chronic infections
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and inflammation as major risk factors for various types of cancer. It has been estimated that the
underlying infections and inflammatory reactions are linked to 15%–20% of all cancer deaths [2].
The inflammatory response is characterized by coordinate activation of various signaling
pathways that regulate expression of both pro- and anti-inflammatory mediators in cells of inflamed
tissue as well as leukocytes recruited from the blood. The nuclear transcription factor κB (NF-κB) is
the master regulator of the inflammatory response, that drives the activation of genes associated
with the transcription of inflammatory mediators, such as interleukins, tumor necrosis factor-α
(TNF-α) and prostaglandins (PGs), as well as inflammatory enzymes, like inducible nitric oxide
synthase (iNOS) and cyclooxygenases (COXs). Several classes of medicines, including corticosteroids,
nonsteroidal anti-inflammatory drugs (NSAIDs) and biologics drugs are used to treat the inflammatory
disorders. However, they possess several side effects and the biologics ones are expensive to be used.
To limit these drawbacks of both synthetic and biologic drugs, over the past three decades, the use of
herbal medicines, nutraceuticals and food supplements has increased greatly as an alternative and/or
complementary medicine to treat several pathologies, including inflammation [3]. Indeed, although
natural products are not devoid of risk, generally they are safer than both synthetic and biologic
drugs. Nowadays, about 80% of people around the world use natural products for the prevention
and treatment of many diseases, mainly for their relative safety, efficacy and low cost as well as the
compliance by patients. Plants have been the basis of many traditional medicines throughout the
world for thousands of years, and continue to provide mankind with new remedies [4]. In this field,
natural products offer great hope in the identification of bioactive molecules useful for the treatment
of inflammatory diseases, as it happened for aspirin, the first discovered NSAID, which is still one
of the bestselling drugs in the world. Polyphenols, such as flavonoids, lignans, phloroglucinols,
quinones, stilbenes, phenylpropanoids, and diarylheptanoids, are a very important category of natural
compounds able to modulate inflammatory pathways. Among them, luteolin [5,6], quercetin [7],
wogonin [8,9], apigenin [6,8], fisetin [6] and baicalein [6] showed anti-inflammatory activity in vitro
and in animal models.
A growing volume of evidence supports the hypothesis that the use of a phytocomplex, such as an
extract, can have a greater preventive and therapeutic success than a single biomolecule, because of both
additive and synergistic effects of their individual constituents [10–13]. Moreover, all phytochemicals
present in whole extracts may simultaneously modulate different targets of action in human cells,
leading to a mixture of pharmacological effects contributing together to improve patient’s health [14,15].
Hence, we and other researchers have started investigating the anti-inflammatory action of a number
of phytocomplexes in a context of a multitarget pharmacological strategy.
In this review, we present an overview of the anti-inflammatory properties of bergamot extracts
that could be the scientific basis for the development of novel and alternative strategies aimed to
prevent and/or treat inflammatory conditions.
2. Oxidative Stress and Inflammation
Inflammation and oxidative stress are closely related pathophysiological events that are strongly
linked with one another. One of them may appear before or after the other, but when one emerges
the other one is most likely to follow and then both of them take part in the pathogenesis of many
disorders. Nowadays, it is clear that the prolonged low-grade inflammatory process plays a central
role in the pathogenesis of many chronic diseases [16]. On the other hand, epidemiological and
experimental studies strongly suggest a contribution of oxidative stress in many human diseases [16].
Just as the inflammatory process can induce oxidative stress, the latter can cause inflammation through
activation of multiple pathways [17,18]. The result is that both inflammation and oxidative stress are
associated with a number of chronic diseases, including diabetes, hypertension, cardiovascular diseases,
neurodegenerative diseases, alcoholic liver disease, chronic kidney disease, cancer, and aging [19–22].
Under pathological inflammatory conditions there may be exaggerated generation of reactive
species (RS) that can diffuse out of the cells, inducing localized oxidative stress and tissue injury [23].
Molecules 2016, 21, 1273 3 of 11
Moreover, the activated phagocytic cells produce large amounts of radical oxygen and reactive nitrogen
species (ROS and RNS, respectively). Once generated, they can further generate other RS, leading to
extensively damage. At the onset of inflammation, the infection or tissue damage is sensed by the
pattern recognition receptors like toll-like receptors (TLR), NOD-like receptors (NLR), and the receptor
for advanced glycation end products (RAGE). The stimulation of these receptors upon binding with
specific molecules leads to the activation of transcription factors such as nuclear factor-κB (NF-κB) and
activating protein-1 (AP-1), that in turn induce pro-inflammatory gene expression, exert antimicrobial
functions and recruit additional immune cells [24,25]. It has been demonstrated that RS (i.e., hydrogen
peroxide) can induce inflammation through activation of these same transcription factors [26–28].
Over the last decades, researchers have investigated on the effectiveness of antioxidants in
preventing diseases like cardiovascular diseases, cancer, diabetic complications, Alzheimer’s disease,
and so forth [29]. Most of the results come from in vitro studies, and clinical researches have produced
controversial data, although many epidemiological data suggest that antioxidants may have a beneficial
effect in many chronic diseases. However, great care should be taken in the choice of antioxidant
agents and their dosage, as well as, it is most important to quantify the redox and inflammatory status
to make appropriate interpretation of the findings.
3. Bergamot Derivatives
Known as “bergamot”, Citrus bergamia Risso et Poiteau is a small plant belonging to the Rutaceae
family, growing spontaneously in the southern coast of Calabria region (Italy), where the particular
microclimate is ideal for its cultivation [30]. Bergamot fruit is used especially for the extraction of its
essential oil (BEO) from the peel (by cold pressing), while the bergamot juice (BJ), derived squeezing
the endocarp of the fruits, is considered a byproduct of the BEO’s production. Finally, the scraps of
bergamot fruit after both BEO extraction and BJ juicing is named “bergamot pastazzo” and is used
as animal feed. BEO is typically used in the cosmetic industry, being found in the composition of
many fragrances, body lotions, soaps and so on. It is also used by the food industries (for flavoring
tea, beverages and typical Calabrian pastries), by the pharmaceutical industries (to absorb the
unpleasant smell of medicinal products and for its antiseptic and antibacterial properties [31]) and in
aromatherapy [30]. Over the last decade, some researchers have started to investigate the biological
properties of bergamot derivatives, obtaining important scientific achievements. For example, BEO has
been evaluated for its potential neuroprotective [32] and antiproliferative effects [11,33], while BJ
has been suggested as antioxidant [34,35], anti-inflammatory [36–39], anticancer [15,40–42] and
hypolipidemic [43,44] drug.
The chemical composition of the main Citrus bergamia derivatives, BEO and BJ, has been
studied mostly by high performance liquid chromatography–mass spectrometry (HPLC-MS),
gas chromatography–mass spectrometry (GC-MS) and gas chromatography–flame ionization detection
(GC-FID) techniques, and has been reported in a number of papers [41,45–48]. BEO is composed of
both volatile and non-volatile fractions that account for 93%–96% and 4%–7% of the total, respectively.
The non-volatile components are responsible for phototoxic reactions at certain concentrations, due to
the presence of furanocoumarins (or furocoumarins), especially bergapten [30]. The main constituents
of BEO are terpens and furanocoumarins, among which limonene, linalyl acetate (terpens) and
bergamottin (furanocoumarins) are the most abundant molecules. Other compounds present in fewer
amounts are the terpenes linalool and γ-terpinene, the coumarins 5-geranyloxy-7-methoxycoumarin
and citropten, as well as the furanocoumarin bergapten [30]. Their chemical structures are presented
in Table 1. BJ is characterized by the presence of high amount of flavonoids among which naringin,
neohesperidin, neoeriocitrin and eriocitrin are the most abundant, although melitidin, hesperetin and
naringenin are also present [36,41,46]. The major flavonoids in BJ and their molecular structures are
shown in Table 2.
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Table 1. The main constituents of BEO and their chemical structures.
BEO
Coumarins and Furanocoumarins Terpenes
Name Molecular Structure Name Molecular Structure
Bergamottin
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3. Antioxidant Properties of Bergamot Derivatives 
Antioxidant compounds play an important protective role in the prevention of numerous 
diseases. Although the antioxidant activity of BJ has been previously addressed [55], recently we better 
characterized the chemical composition of a flavonoid-rich extract from BJ (BJe), and then investigated 
its antioxidant properties in both abiotic and cell-based assays [34,35]. First we tested the antioxidant 
activity of BJe using a range of tests (Folin-Ciocalteu, Reducing Power, DPPH and ORAC assays) that 
highlighted its great antioxidant and radical scavenging properties related to the high total phenol 
content [34]. Then, we focused on the cytoprotective ability of BJe against oxidants, such as hydrogen 
peroxide (H2O2) and (Fe2SO4)3, that cause oxidative cell damage [34,35]. We found that BJe prevented 
either H2O2 or (Fe2SO4)3-induced oxidative damage on the A549 cells by different mechanisms 
depending from the stressor agent. Indeed, the extract (25 or 50 µg/mL) reduced ROS generation and 
counteracted the membrane lipid peroxidation, improved mitochondrial functionality and prevented 
DNA-oxidative damage in A549 cells incubated with H2O2 or (Fe2SO4)3. We further described the 
chelating property of BJe in iron-exposed cells, thus blocking upstream redox activity as well as its 
capability to induce antioxidant catalase. Overall, our results show that BJe exerts its antioxidant 
properties through different complementary via: scavenging free radicals, metal ion chelation and 
boost of cellular antioxidant defense. 
Trombetta et al. [56] evaluated the antioxidant/anti-inflammatory activity of two alcoholic 
flavonoid-rich extracts from bergamot peel on human vessel endothelial cells (HUVECs) exposed to 
the pleiotropic inflammatory cytokine TNF-α, a model of vascular oxidative stress. As hallmarks of 
oxidative damage in TNF-α-exposed HUVECs, the Authors monitored cell viability, intracellular 
levels of MDA/HNE, GSH and GSSG, and SOD activity. They showed that both extracts prevented 
the oxidative stress induced by TNF-α, modulated the activation of redox-sensitive transcription 
factors NF-κB, thus increasing the cell survival. 
4. Anti-Inflammatory Activity of Bergamot Derivatives 
The anti-inflammatory activity of bergamot derivatives has been demonstrated in both in vitro 
and in vivo studies. Karaca et al. [57] investigated for the anti-inflammatory activity of BEO using 
carrageenan-induced rat paw oedema test. The authors found that reduction in the inflammation, 
measured as reduction of paw volume, was 95.70% with indomethacin used as standard control, 
27.56% with 0.025 mL/kg BEO, 30.77% with 0.05 mL/kg BEO and 63.39% with 0.10 mL/kg BEO (ED50 
value of 0.079 mL/kg). Borgatti et al. [58] have analyzed the effects of a bergamot epicarp extract and 
the isolated cumarins on the production of IL-8 (mRNA levels and protein release) in cystic fibrosis 
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A number of researchers have documented the capability of molecules present in both BEO and
BJ to counteract inflammation via modulation of several pathways. For example, the pharmacological
functions of coumarins, including their anti-inflammatory activity, were reviewed by Wu et al.
i 2009 [49], and very recently by Srikrishna t al. [50], while the anti-inflamma ry profile d
the structure-activity r lation hip of terpe es was discussed by S uza coworkers in systematic
review [51]. The i-infl mmatory properti s of some BJ flavonoi s as pure compounds have been
extensively i vestigated and w ll es ablished in sever l experimental models [52–54].
4. Antioxidant Properties of Berg mot Derivatives
Antioxidant compounds play an important protective role in the prevention of numerous diseases.
Alth gh the antioxid t activity of BJ has been previously addressed [55], recently we better
characterized the chemical composition of a flavonoid-rich extract from BJ (BJe), and then investigat d
its an oxidant properties in b th abiotic and ce l-based assays [34,35]. First we tes ed the antioxidant
activity of BJe using a r ge of tests (Folin-Cioc teu, Red cing Power, DPPH and ORAC ass ys)
that highlighted its great antioxidant and radic l sc e ging properties related to t e high total
phenol content [34]. Then, we focused on the cytoprotective ability of BJe against oxidants, such as
hydrogen peroxide (H2O2) and (Fe2SO4)3, that cause oxidative cell damage [34,35]. We found that
BJe prevented either H2O2 or (Fe2SO4)3-induced oxidative damage on the 549 cells by different
mechanisms epending from the stressor agent. Indeed, t e extract (25 or 50 µg/mL) reduced ROS
generation and counter cted the membrane lipid perox dati n, improved mitochond i l functio ality
and preven ed DNA-oxidative damage in A549 c lls incuba ed with H2O2 or (Fe2SO4)3. We further
de cribed the chelating p operty of BJe in iron-exposed cells, thus blocking upstream redox activity
as well as its capability to induce antioxidant catalase. Overall, our results show that BJe exerts
its antioxidant properties through different complementary via: scavenging free radicals, metal ion
chelation a d boost f cellular antioxidant defense.
Tr mbetta et al. [56] ev luated the antioxidant/anti-inflammatory activi y of two alcoholic
flavo oid-rich extracts f om bergamot p l on huma vessel ndoth lial cells (HUVECs) exposed
to the pleiotropic inflammat ry cyt kine TNF-α, a model of vascular oxidative st ess. As hallmarks
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of oxidative damage in TNF-α-exposed HUVECs, the Authors monitored cell viability, intracellular
levels of MDA/HNE, GSH and GSSG, and SOD activity. They showed that both extracts prevented the
oxidative stress induced by TNF-α, modulated the activation of redox-sensitive transcription factors
NF-κB, thus increasing the cell survival.
5. Anti-Inflammatory Activity of Bergamot Derivatives
The anti-inflammatory activity of bergamot derivatives has been demonstrated in both in vitro
and in vivo studies. Karaca et al. [57] investigated for the anti-inflammatory activity of BEO using
carrageenan-induced rat paw oedema test. The authors found that reduction in the inflammation,
measured as reduction of paw volume, was 95.70% with indomethacin used as standard control,
27.56% with 0.025 mL/kg BEO, 30.77% with 0.05 mL/kg BEO and 63.39% with 0.10 mL/kg BEO (ED50
value of 0.079 mL/kg). Borgatti et al. [58] have analyzed the effects of a bergamot epicarp extract and
the isolated cumarins on the production of IL-8 (mRNA levels and protein release) in cystic fibrosis
IB3-1 and CuFi-1 cells treated with TNF-α or heat-inactivated Pseudomonas aeruginosa. Particularly,
they showed as the most active molecules were bergapten and citropten, typically present in BEO.
Other researchers studied the potential anti-inflammatory activity of the polyphenolic fraction of
BJ on normal human NCTC 2544 keratinocytes exposed to interferon-gamma (IFN-γ) or histamine
(H) [59]. The juice was obtained from peeled fruits by industrial pressing and squeezing. The juice
was filtered and loaded on column absorbing polyphenols. Then, polyphenolic fraction was eluted
by hydroalcoholic acid solution (60:40 v/v) and dried by spray-drying. IFN-γ is an essential cytokine
in amplifying inflammatory reactions, which stimulates the synthesis of chemokines, that in turn
attract inflammatory cells and induces the expression of inducible intercellular adhesion molecule-1
(ICAM-1). Moreover, the over-secretion of inflammatory cytokines triggers an abnormal accumulation
of extracellular matrix components such as glycosaminoglycans (GAGs) [60,61]. Keratinocytes are the
major constituents of the epidermis, and in inflamed skin they up-regulate various pro-inflammatory
activators, such as PGE2, NO, ROS and cytokines [62]. They are actively engaged in skin inflammatory
responses by attracting leukocytes and modulating their functions. The assays performed on
keratinocytes demonstrated that the bergamot extract significantly reduces ICAM-1, NO, ROS and
GAG production in cells exposed to IFN-γ and H in concentration-dependent manner [59]. Moreover,
these Authors observed similar results when they employed neoeriocitrin, naringin or neohesperidin,
the most abundant flavonoids of the BJ. Of note, the antioxidant/anti-inflammatory effect of the wool
extract was superior than that of each flavonoid used alone [59].
Nisticò and coworkers [63] evaluated the effect of a 38% bergamot polyphenolic fraction
(BPF) on UVB-induced photoageing by examining inflammatory cytokine expression, telomere
length/telomerase alterations and cellular viability in human immortalized HaCaT keratinocytes
subjected to ultraviolet (UV) radiation. They clearly showed as the phytocomplex protected HaCaT
cells against UVB-induced oxidative stress, reducing IL-1β mRNA expression and restores telomere
length and activity.
Experiments performed in our research lab demonstrated that BJe is able to significantly reduce the
LPS-pro-inflammatory action in THP-1 cells [36]. Indeed, we demonstrated that the extract inhibited
both gene expression and secretion of LPS-induced pro-inflammatory cytokines (IL-6, IL-1β, TNF-α).
Then, given the reported key role of NF-κB in inflammatory response induced by various stimuli,
we also investigated its role in THP-1 cells exposed to LPS, showing that BJe was able to inhibit this
important transcription factor. It is known that polyphenols could influence cellular function by acting
as activators of SIRT1, a nuclear histone deacetylase involved in the inhibition of NF-κB signaling.
Therefore, in a subset of experiments we also investigated the capability of BJe to modulate SIRT1,
evidencing that the extract activated SIRT1, that in turn reduced the LPS-enhanced acetylation of p65
in THP-1 cells [36].
In the light of these observations, we wondered whether BJe may be beneficial against
neuroinflammatory processes, such as those observed in Alzheimer’s disease, where the chronic
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activated glial cells amplify the neurotoxicity by secreting pro-inflammatory mediators like cytokines.
Hallmarks of chronic inflamed tissues are the presence of an increased number of monocytes, as
well as monocyte-derived tissue macrophages, that can be referred to microglial cells in the central
nervous system (CNS) [64]. To this aim we investigated the effectiveness of BJe in THP-1 cells exposed
to amyloid-beta (Aβ), an experimental model of circulating monocytes/macrophages that resemble
neuroinflammatory condition [38]. Exposure of THP-1 cells to Aβ significantly induced the expression
and secretion of IL-6 and IL-1β in THP-1 cells, and increased the phosphorylation of ERK 1/2 as well
as p46 and p54 members of JNK family. These effects were reduced by the pre-treatment with BJe,
confirming its anti-inflammatory potential. Some results show that increased cytokine expression
may be due to different transcription factors, such as AP-1. Notably, in this research we observed that
the increased AP-1 DNA binding activity in Aβ-treated cells was reduced by the pretreatment with
BJe [38].
The anti-inflammatory activity of BJe has also been demonstrated in animal models. In an
in vivo model of inflammatory bowel disease, we have shown that BJe attenuated the inflammation by
dinitrobenzene sulfonic acid (DNBS) [37]. The BJe-treated mice were more resistant to DNBS-induced
colitis and showed less macroscopic and histological signs of inflammatory process. Moreover, the
expression of important inflammatory mediators, such as TNF-α and IL-1β, as well as the neutrophil
infiltration, were reduced in the colon tissues of DNBS-injected mice as consequence of BJe treatment.
We also reported that BJe reduced the increase of p-JNK expression, and inhibited the NF-κB activation
in the colon of DNBS-treated animals. In addition, we found reduced expression of adhesion molecules
(ICAM-1 and P-selectin), nitrotyrosine, poly (ADP ribose) synthetase (PAR) and apoptosis related
proteins in DNBS-injected mice treated with BJe [37].
The beneficial effects of BJe have been also demonstrated in ileum inflammation triggered by
intestinal ischemia/reperfusion (I/R) injury in mice [39]. The experimental results confirmed that
BJe was able to reduce histological damage, cytokines production (TNF-α and IL-1β), ICAM-1 and
P-selectin expression, myeloperoxidase (MPO) activity and oxidative stress (malondialdehyde, MDA;
manganese superoxide dismutase, mnSOD and inducible nitric oxide synthase, iNOS) by a mechanism
involved both NF-κB and MAP kinases (JNK and p38) pathways.
The studies on the anti-inflammatory effect of bergamot derivatives collected in this review are
summarized in Table 3.
Table 3. Principal characteristics of studies on anti-inflammatory effect of bergamot derivatives.
Compound Study Model Determinations References
BEO Carrageenan-inducedinflammation Paw volume
Karaca et al.;
2007 [57]
Extract from
bergamot peel
Endotelial oxidative
stress/inflammation
MDA, 4-HNE, GSSG,
GSH/GSSG, SOD
Trombetta et al.;
2010 [56]
Extract from
bergamot epicarp Cystic fibrosis IL-8
Borgatti et al.;
2011 [58]
Extract from
bergamot juice and
flavonoids
Skin inflammation ICAM-1, iNOS, NO, ROS, GAG Graziano et al.;2012 [59]
Extract from
bergamot juice Activated monocytes IL-1β, IL-6, TNF-α, NF-κB, SIRT-1
Risitano et al.;
2014 [36]
Extract from
bergamot juice Colitis
IL-1β, TNF-α, MPO, nitrotyrosine,
p-JNK, ICAM-1, P-selectin PAR,
NF-κB, BAX, BCL-2
Impellizzeri et al.;
2014 [37]
Extract from
bergamot juice Lung oxidative stress
ROS, lipid peroxidation,
mitochondrial potential, DNA damage
Ferlazzo et al.;
2015 [34]
Extract from
bergamot juice Skin photoaging IL-1β, telomerase activity
Nisticò et al.;
2015 [63]
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Table 3. Cont.
Compound Study Model Determinations References
Extract from
bergamot juice Neuroinflammation IL-1β, IL-6, ERK1/2, p-JNK, AP-1
Currò et al.;
2016 [38]
Extract from
bergamot juice Lung oxidative stress
ROS, lipid peroxidation, mitohcondrial
potential, DNA damage, catalase
Ferlazzo et al.;
2016 [35]
Extract from
bergamot juice
Intestinal
ischemia/reperfusion injury
histological alterations, IL-1β, TNF-α,
MDA, MnSOD, ICAM-1, P-selectin,
NF-κB, iNOS, p-p38, p-JNK
Impellizzeri et al.;
2016 [39]
6. Conclusions
Despite the remarkable medical advances, inflammation remains a serious health problem.
Recently, interest in natural product has led both researchers and the wellness industry to explore
natural sources for alternative and complementary medicine to prevent and/or treat inflammatory
diseases. Several studies on the beneficial effects of bergamot derivatives in the inflammation field
have been published, increasing the attention towards this Citrus species as a potential source of
natural antioxidant/anti-inflammatory remedies. This is the first review that collects and critically
reports the literature on this topic. It may represent a scientific basis for the development of novel
strategies to improve health status and attenuate inflammatory conditions.
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